Three Purposes for Pharmacogenetic Testing

Howie Bartz is a summa cum laude graduate of Daemen College. In 2007, he founded Meditech, LLC, a provider of durable medical equipment and ancillary services. Through this company, Howie Bartz offers pharmacogenetic testing.

More than 2.2 billion cases of adverse drug events (ADE) occur every year, with as many as 100,000 events resulting in death. Pharmacogenetic testing is helpful in identifying potential ADEs and detecting individuals who are one of the 20 percent to 30 percent of pain patients who suffer from a genetic opioid metabolic defect (GOMD). Pharmacogenetic testing also helps increase drug efficacy. Presently, less than 60 percent of patients taking prescription pain medication enjoy a mitigation of symptoms. In these situations, an increased dosage can lead to an overdose. In fact, prescription opioid overdoses account for more deaths than cocaine and heroin combined as of 2014. Finally, pharmacogenetic testing can improve patient compliance because patients who receive genetic test results are more compliant with prescription guidelines.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s